Interaction of Alcohol and Other Potentially Cardiotoxic Substances with the Cardiovascular System

Overview

Journal Herz

Specialty Cardiology & Vascular Diseases

Date 2024 Nov 27

PMID 39601836

Authors

Bernhard Maisch

Affiliations

Soon will be listed here.

References

Bhatia H, Nishimura M, Dickson S, Adler E, Greenberg B, Thomas I . Clinical and echocardiographic outcomes in heart failure associated with methamphetamine use and cessation. Heart. 2020; 107(9):741-747. PMC: 8842989. DOI: 10.1136/heartjnl-2020-317635. View

Zhao J, Stockwell T, Naimi T, Churchill S, Clay J, Sherk A . Association Between Daily Alcohol Intake and Risk of All-Cause Mortality: A Systematic Review and Meta-analyses. JAMA Netw Open. 2023; 6(3):e236185. PMC: 10066463. DOI: 10.1001/jamanetworkopen.2023.6185. View

Hasan A, von Keller R, Friemel C, Hall W, Schneider M, Koethe D . Cannabis use and psychosis: a review of reviews. Eur Arch Psychiatry Clin Neurosci. 2019; 270(4):403-412. DOI: 10.1007/s00406-019-01068-z. View

Connor S, Sexton G, Connor W . Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation. 1993; 88(6):2771-9. DOI: 10.1161/01.cir.88.6.2771. View

Sarafian T, Magallanes J, Shau H, Tashkin D, Roth M . Oxidative stress produced by marijuana smoke. An adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol. 1999; 20(6):1286-93. DOI: 10.1165/ajrcmb.20.6.3424. View

Renaud S, de Lorgeril M . Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992; 339(8808):1523-6. DOI: 10.1016/0140-6736(92)91277-f. View

St Leger A, Cochrane A, Moore F . Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet. 1979; 1(8124):1017-20. DOI: 10.1016/s0140-6736(79)92765-x. View

Tobolski J, Sawyer D, Song S, Afari M . Cardiovascular disease associated with methamphetamine use: a review. Heart Fail Rev. 2022; 27(6):2059-2065. DOI: 10.1007/s10741-022-10261-7. View

Arenas D, Beltran S, Zhou S, Goldberg L . Cocaine, cardiomyopathy, and heart failure: a systematic review and meta-analysis. Sci Rep. 2020; 10(1):19795. PMC: 7666138. DOI: 10.1038/s41598-020-76273-1. View

10.

Jeffers A, Glantz S, Byers A, Keyhani S . Association of Cannabis Use With Cardiovascular Outcomes Among US Adults. J Am Heart Assoc. 2024; 13(5):e030178. PMC: 10944074. DOI: 10.1161/JAHA.123.030178. View

11.

Wood D, Dargan P, Hoffman R . Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction. Clin Toxicol (Phila). 2008; 47(1):14-23. DOI: 10.1080/15563650802339373. View

12.

Maisch B . [Canada's guidance on alcohol and health : A paradigm shift]. Herz. 2023; 49(1):43-49. DOI: 10.1007/s00059-023-05226-x. View

13.

Pacher P, Steffens S, Hasko G, Schindler T, Kunos G . Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol. 2017; 15(3):151-166. DOI: 10.1038/nrcardio.2017.130. View

14.

Volkow N, Baler R, Compton W, Weiss S . Adverse health effects of marijuana use. N Engl J Med. 2014; 370(23):2219-27. PMC: 4827335. DOI: 10.1056/NEJMra1402309. View

15.

Chen C, Huo C, Mattey-Mora P, Bidulescu A, Parker M . Assessing the association between e-cigarette use and cardiovascular disease: A meta-analysis of exclusive and dual use with combustible cigarettes. Addict Behav. 2024; 157():108086. DOI: 10.1016/j.addbeh.2024.108086. View

16.

Di Castelnuovo A, Costanzo S, Bagnardi V, Donati M, Iacoviello L, de Gaetano G . Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006; 166(22):2437-45. DOI: 10.1001/archinte.166.22.2437. View

17.

George J, Hussain M, Vadiveloo T, Ireland S, Hopkinson P, Struthers A . Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes. J Am Coll Cardiol. 2019; 74(25):3112-3120. PMC: 6928567. DOI: 10.1016/j.jacc.2019.09.067. View